Progression and monitoring of disease is paramount to understanding better drug design, safety, and efficacy. From basic research models to clinically translatable applications, our in vivo community of pre-clinical researchers publishes on a daily basis. Over 3,500 papers in peer-reviewed journals have been published to date, covering a wide range of therapeutic applications in bioluminescence, fluorescence, tomography and multimodal imaging.
In vivo imaging enables researchers to identify disease pathways, determine mechanisms of action, evaluate drug compounds and monitor their effects on disease progression in living animals. Imaging of human tissues is becoming more widely used early in the drug discovery process as it ensures proposed targets are expressed in disease-relevant tissues or clinical samples, helping to reduce risk of failure in late clinical trial stages.
PerkinElmer provides a suite of solutions for studying complex biological systems focused on in vivo and tissue imaging: